CFP
CFP (complement factor properdin, also known as properdin or PFC) is a secreted plasma glycoprotein that positively regulates the alternative pathway of complement. It binds and stabilises the C3- and C5-convertase enzyme complexes of the innate immune system. Browse Assay Genie's current range of CFP research reagents below, or read on for the biology behind the target.
CFP is a positive regulator of the alternative pathway (AP) of complement. It binds to and stabilises the C3- and C5-convertase enzyme complexes, and it inhibits CFI-CFH mediated degradation of the complement C3 beta chain (C3b). By protecting these complexes, properdin supports a feedback loop that ultimately leads to formation of the membrane attack complex and lysis of the target cell.
The CFP gene encodes a plasma glycoprotein that is secreted. The protein binds to many microbial surfaces and apoptotic cells, which places it among the soluble pattern recognition molecules, the HGNC gene group to which it belongs alongside the complement system activation components. Multiple alternatively spliced transcript variants have been identified, and all of them encode the same protein. Researchers working on the CFP gene or properdin protein will often study it in the context of alternative pathway activation and convertase stability.
CFP was previously named properdin P factor, complement, and the older symbol PFC is still found in the literature. Mutations in the gene result in two forms of properdin deficiency, which is associated with high susceptibility to meningococcal infections. This link makes CFP a useful reference point for understanding how complement amplification contributes to host defence against bacterial pathogens. A mouse ortholog, Cfp, is recognised.
CFP stabilises C3- and C5-convertases and inhibits CFI-CFH mediated degradation of C3b, making it central to studies of alternative pathway amplification.
Properdin binds many microbial surfaces, and its deficiency confers high susceptibility to meningococcal infections, linking it to host defence research.
CFP binds apoptotic cells as well as microbes, so it is relevant to work on how complement recognises and targets altered host surfaces.
The convertase feedback loop stabilised by CFP ultimately leads to membrane attack complex assembly and target cell lysis.
CFP, or properdin, is a positive regulator of the alternative complement pathway. It binds to and stabilises the C3- and C5-convertase complexes and inhibits CFI-CFH mediated degradation of C3b, sustaining a feedback loop that leads to membrane attack complex formation and lysis of the target cell.
Yes. Properdin is the UniProt protein name, and PFC is a previous gene symbol. The gene was also formerly named properdin P factor, complement. The HGNC approved name is complement factor properdin. Alternatively spliced variants of the gene all encode the same protein.
Mutations in CFP cause two forms of properdin deficiency, which results in high susceptibility to meningococcal infections. A mouse ortholog, Cfp, exists; check the datasheet of any product for its validated reactivity.
Other complement components and regulators involved in alternative pathway activation and innate immunity.
Gene and protein annotations from HGNC, NCBI Gene and UniProt P27918; product specifications from Assay Genie datasheets.